JYLAMVO
LIVE

Serial Number

98183585

Owner

Shorla Pharma Limited

Attorney

Sean P. McMahon

First Use Date

Feb 7, 2025

Filing Date

Sep 17, 2023

Add to watchlist:

No watchlists yet
View on USPTO

JYLAMVO Trademark

Serial Number: 98183585 • Registration: 8079127

JYLAMVO is a trademark filed by Shorla Pharma Limited on September 17, 2023. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

Shorla Pharma Limited (11 trademarks)

Questum Acceleration Centre
Clonmel, Co. Tipperary E91V239 , IE

Entity Type: 99

Trademark Details

Filing Date

September 17, 2023

Registration Date

December 23, 2025

First Use Anywhere

February 7, 2025

First Use in Commerce

February 7, 2025

Published for Opposition

February 4, 2025

Goods & Services

Biological research; Biotechnology research; Medical and scientific research information in the field of pharmaceuticals and biotechnology; Pharmaceutical drug development services; Pharmaceutical product evaluation; Pharmaceutical research and development; Pharmaceutical research services; Providing information about medical and scientific research; Providing medical and scientific research information; Providing medical and scientific research information in the field of clinical trials; Research and development in the pharmaceutical and biotechnology fields; Scientific research; Testing of pharmaceuticals

Anti-cancer preparations; Medicinal preparations for use in oncology; Pharmaceutical preparations for the treatment and prevention of oncological diseases and disorders, dermatological diseases and disorders, autoimmune and inflammatory diseases and disorders; Pharmaceutical preparations for the treatment and prevention of cancer; Pharmaceutical preparations for the treatment and prevention of tumors; Pharmaceutical preparations for the treatment of oncological diseases and disorders, dermatological diseases and disorders, autoimmune and inflammatory diseases and disorders; Pharmaceutical preparations for use in oncology

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
Dec 23, 2025 NRCC
REGISTERED-PRINCIPAL REGISTER
Dec 23, 2025 R.PR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Dec 3, 2025 SUNA
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Dec 3, 2025 CNPR
STATEMENT OF USE PROCESSING COMPLETE
Nov 10, 2025 SUPC
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Nov 10, 2025 AITU
USE AMENDMENT FILED
May 28, 2025 IUAF
TEAS STATEMENT OF USE RECEIVED
May 28, 2025 EISU
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Apr 1, 2025 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Feb 4, 2025 NPUB
PUBLISHED FOR OPPOSITION
Feb 4, 2025 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jan 29, 2025 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jan 11, 2025 CNSA
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
May 10, 2024 GNS3
LETTER OF SUSPENSION E-MAILED
May 10, 2024 GNSL
SUSPENSION LETTER WRITTEN
May 10, 2024 CNSL
ASSIGNED TO EXAMINER
May 10, 2024 DOCK
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Apr 25, 2024 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Apr 25, 2024 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Apr 25, 2024 REAP
NOTICE OF DESIGN SEARCH CODE E-MAILED
Dec 1, 2023 MDSC
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Dec 1, 2023 NWOS
NEW APPLICATION ENTERED
Sep 17, 2023 NWAP